[Skip to Navigation]
December 1983

Radiobiologic Research for Head and Neck Cancer Therapy: Therapeutic Implications

Author Affiliations

From the Joint Center for Radiation Therapy, Harvard Medical School (Drs Weichselbaum and Rose), and the Division of Medicine, Dana-Farber Cancer Institute (Drs Ervin and Miller), Boston.

Arch Otolaryngol. 1983;109(12):792-796. doi:10.1001/archotol.1983.00800260014004

• Hypoxic cell sensitizers, particle therapy, hyperthermia, and combinations of chemotherapy and radiotherapy have potential to increase the therapeutic ratio in future clinical radiotherapy treatment regimens. The biologic bases of these investigations are beginning to appear as avenues of clinical investigation.

(Arch Otolaryngol 1983;109:792-796)

Add or change institution